Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GZMO -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (153)	10/23/1999 11:16:00 PM
From: scaram(o)uche	Respond to of 438

link to the abstract....... aacr.edoc.com Irradiated Autologous* Prostate Tumor Cells*

To: scaram(o)uche who wrote (153)	10/24/1999 8:51:00 PM
From: jeffbas	Read Replies (1) \| Respond to of 438

<<and the shares have done zip>> Rick, I agree with your sentiment with respect to the stock's performance. However, I believe that there is an explanation other than Holaday. If you read the Yahoo thread around the time of the aaATIII Science article, it seems clear to me that there were a lot of speculators who bought the stock knowing nothing about the company, thinking it would zoom like ENMD when the article was published. There were a lot of shares sold to these folks those few days. I think we have to work through their loss-taking before a sustained uptrend can begin. In other words, if in 3 months it is announced that the CEGE deal has been concluded the stock would rise even though that is not new news. If they said at that time the melanoma trials are doing great, maybe we even add 3 points. But now, we have to get through the people who can't stand this "dog" of a stock. What is the Id1/Id3 manuscript in Nature about? Can you provide a link?